The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of two anti-coagulant formulations and 51 drugs in a notification dated June 28 effectively bringing down their prices.
The pricing authority has set the retail prices for Dabigatran formulation- an anti-coagulant (used to treat and prevent blood clots) at Rs 35.59 for a 150-gram capsule.
The price of 24 anti-diabetic formulations containing dapagliflozin, another 14 with vildagliptin and two with sitagliptin molecules were also set.
Paroxetine controlled release & Clonazepam capsules for the treatment of depression will be priced at Rs 15.81 per capsule.
The ceiling price is the amount fixed by the government for Scheduled Formulations in accordance with the provisions of the Drugs (Prices Control) Order, 2013. It is the maximum price for retailers (excluding GST, if any) for a given product.
In case the retail price of any of the above formulations is not complied with, as per instant price notification, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the DPCO 2013, read with the Essential Commodities Act, 1955, the notification said.
The NPPA had also fixed the ceiling prices of 18 formulations and 23 new drugs on June 8.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
